Terns Pharmaceuticals, Inc. TERN
Set alert
52.95 USD 0.00 0.00%
At close · May 15
52.97 +0.02 +0.04%
After hours · May 15, 4:00 PM ET
52.95 Day range 52.97
7.87 52-week range 53.19
- YTD
- +31.06%
- 1 year
- +1,797.85%
- Open
- 52.97
- Prev close
- 52.95
- Mkt cap
- 6.12B
- Vol
- 6.33M
- Avg vol
- 4.84M
- EPS
- -1.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 52.95
- High
- 52.97
- Beta
- -0.38
- Inst. own
- 109.69%
- Dividend
- 0.00
3M chart
Events in this range
- Mar 26, 2026Downgrade: TD Cowen · Buy → Hold
- Mar 26, 2026Downgrade: Citizens · Market Outperform → Market Perform
- Mar 30, 2026Earnings: -0.25; estimate -0.29; surprise 13.79%
- Mar 30, 2026Downgrade: Barclays · Overweight → Equal-Weight
- Mar 31, 2026Downgrade: Truist Securities · Buy → Hold
- Apr 14, 2026Rating: JP Morgan · Overweight → Overweight
- Apr 27, 2026Downgrade: Oppenheimer · Outperform → Perform
Signals (5)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Apr 7, 2026 | 6 months ago |
| RSI: Overbought | Mar 23, 2026 | 7 months ago |
| RSI: Overbought | Mar 19, 2026 | 7 months ago |
| RSI: Overbought | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Feb 17, 2026 | 8 months ago |
Analyst view
Price target (mean) —
Ratings (0m) 6 0 buy · 6 hold · 0 sell
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 10
- 2 months ago 10
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.26333 | -0.32 – -0.22 | -0.26 | -1.3% | 0 | 0.0% | 3 |
| Next quarter | -0.27667 | -0.34 – -0.24 | -0.26 | -6.4% | 0 | 0.0% | 3 |
| Current year | -1.24 | -1.48 – -1.00 | -1.03 | -20.4% | 0 | 0.0% | 2 |
| Next year | -1.56 | -1.82 – -1.29 | -1.24 | -25.5% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 27, 2026 | Oppenheimer | Downgrade | Outperform | Perform |
| Apr 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 31, 2026 | Truist Securities | Downgrade | Buy | Hold |
| Mar 30, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Mar 26, 2026 | Citizens | Downgrade | Market Outperform | Market Perform |
| Mar 26, 2026 | TD Cowen | Downgrade | Buy | Hold |
| Mar 25, 2026 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Dec 11, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Dec 9, 2025 | Truist Securities | Maintained | Buy | Buy |
| Dec 9, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Dec 9, 2025 | BMO Capital | Maintained | Outperform | Outperform |
| Dec 9, 2025 | Barclays | Maintained | Overweight | Overweight |
| Dec 9, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Dec 9, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 26, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 25, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 19, 2025 | Truist Securities | Maintained | Buy | Buy |
| Nov 18, 2025 | BMO Capital | Maintained | Outperform | Outperform |
| Nov 13, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 11, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 4, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Nov 4, 2025 | BMO Capital | Maintained | Outperform | Outperform |
| Nov 4, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 4, 2025 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Nov 4, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 3, 2025 | William Blair | Upgrade | Market Perform | Outperform |
| Nov 3, 2025 | Jefferies | Maintained | Buy | Buy |
| Oct 23, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Oct 22, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 22, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
